Home » Medical Care » Global Anti-tumor Drug Market Size, Status and Forecast 2020-2026

Global Anti-tumor Drug Market Size, Status and Forecast 2020-2026

  129 Pages     Medical Care  

Available Formats      

Report ID: 41999
Published By: QY Research

Summary

This report focuses on the global Anti-tumor Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Anti-tumor Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Roche

Novartis

Celgene

Bristol-Myers Squibb

Amgen

Johnson & Johnson

Pfizer

Takeda

Eli Lilly

AstraZeneca

Astellas

Merck & Co

Sanofi

Bayer

Biogen Idec

Eisai

Teva

Otsuka

Market segment by Type, the product can be split into

Cytotoxic Drugs

Non-cytotoxic Drugs

Market segment by Application, split into

Alkylating Agents

Anti-metabolism Drugs

Platinum Antineoplastic Agents

Anthracycline antitumor drugs

Microtubule Stabilizer

Endocrine Therapy Drugs

Immunotherapy Drugs

Gene Therapy Drugs

Targeted Antineoplastic Drugs

Market segment by Regions/Countries, this report covers

North America

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Anti-tumor Drug status, future forecast, growth opportunity, key market and key players.

To present the Anti-tumor Drug development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Anti-tumor Drug are as follows:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

If you have any special requirements, please let us know and we will offer you the report as you want.

Table Of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Anti-tumor Drug Revenue

1.4 Market Analysis by Type

1.4.1 Global Anti-tumor Drug Market Size Growth Rate by Type: 2020 VS 2026

1.4.2 Cytotoxic Drugs

1.4.3 Non-cytotoxic Drugs

1.5 Market by Application

1.5.1 Global Anti-tumor Drug Market Share by Application: 2020 VS 2026

1.5.2 Alkylating Agents

1.5.3 Anti-metabolism Drugs

1.5.4 Platinum Antineoplastic Agents

1.5.5 Anthracycline antitumor drugs

1.5.6 Microtubule Stabilizer

1.5.7 Endocrine Therapy Drugs

1.5.8 Immunotherapy Drugs

1.5.9 Gene Therapy Drugs

1.5.10 Targeted Antineoplastic Drugs

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends by Regions

2.1 Anti-tumor Drug Market Perspective (2015-2026)

2.2 Anti-tumor Drug Growth Trends by Regions

2.2.1 Anti-tumor Drug Market Size by Regions: 2015 VS 2020 VS 2026

2.2.2 Anti-tumor Drug Historic Market Share by Regions (2015-2020)

2.2.3 Anti-tumor Drug Forecasted Market Size by Regions (2021-2026)

2.3 Industry Trends and Growth Strategy

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porter’s Five Forces Analysis

2.3.5 Anti-tumor Drug Market Growth Strategy

2.3.6 Primary Interviews with Key Anti-tumor Drug Players (Opinion Leaders)

3 Competition Landscape by Key Players

3.1 Global Top Anti-tumor Drug Players by Market Size

3.1.1 Global Top Anti-tumor Drug Players by Revenue (2015-2020)

3.1.2 Global Anti-tumor Drug Revenue Market Share by Players (2015-2020)

3.1.3 Global Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.2 Global Anti-tumor Drug Market Concentration Ratio

3.2.1 Global Anti-tumor Drug Market Concentration Ratio (CR5 and HHI)

3.2.2 Global Top 10 and Top 5 Companies by Anti-tumor Drug Revenue in 2019

3.3 Anti-tumor Drug Key Players Head office and Area Served

3.4 Key Players Anti-tumor Drug Product Solution and Service

3.5 Date of Enter into Anti-tumor Drug Market

3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

4.1 Global Anti-tumor Drug Historic Market Size by Type (2015-2020)

4.2 Global Anti-tumor Drug Forecasted Market Size by Type (2021-2026)

5 Anti-tumor Drug Breakdown Data by Application (2015-2026)

5.1 Global Anti-tumor Drug Market Size by Application (2015-2020)

5.2 Global Anti-tumor Drug Forecasted Market Size by Application (2021-2026)

6 North America

6.1 North America Anti-tumor Drug Market Size (2015-2020)

6.2 Anti-tumor Drug Key Players in North America (2019-2020)

6.3 North America Anti-tumor Drug Market Size by Type (2015-2020)

6.4 North America Anti-tumor Drug Market Size by Application (2015-2020)

7 Europe

7.1 Europe Anti-tumor Drug Market Size (2015-2020)

7.2 Anti-tumor Drug Key Players in Europe (2019-2020)

7.3 Europe Anti-tumor Drug Market Size by Type (2015-2020)

7.4 Europe Anti-tumor Drug Market Size by Application (2015-2020)

8 China

8.1 China Anti-tumor Drug Market Size (2015-2020)

8.2 Anti-tumor Drug Key Players in China (2019-2020)

8.3 China Anti-tumor Drug Market Size by Type (2015-2020)

8.4 China Anti-tumor Drug Market Size by Application (2015-2020)

9 Japan

9.1 Japan Anti-tumor Drug Market Size (2015-2020)

9.2 Anti-tumor Drug Key Players in Japan (2019-2020)

9.3 Japan Anti-tumor Drug Market Size by Type (2015-2020)

9.4 Japan Anti-tumor Drug Market Size by Application (2015-2020)

10 Southeast Asia

10.1 Southeast Asia Anti-tumor Drug Market Size (2015-2020)

10.2 Anti-tumor Drug Key Players in Southeast Asia (2019-2020)

10.3 Southeast Asia Anti-tumor Drug Market Size by Type (2015-2020)

10.4 Southeast Asia Anti-tumor Drug Market Size by Application (2015-2020)

11 India

11.1 India Anti-tumor Drug Market Size (2015-2020)

11.2 Anti-tumor Drug Key Players in India (2019-2020)

11.3 India Anti-tumor Drug Market Size by Type (2015-2020)

11.4 India Anti-tumor Drug Market Size by Application (2015-2020)

12 Central & South America

12.1 Central & South America Anti-tumor Drug Market Size (2015-2020)

12.2 Anti-tumor Drug Key Players in Central & South America (2019-2020)

12.3 Central & South America Anti-tumor Drug Market Size by Type (2015-2020)

12.4 Central & South America Anti-tumor Drug Market Size by Application (2015-2020)

13 Key Players Profiles

13.1 Roche

13.1.1 Roche Company Details

13.1.2 Roche Business Overview and Its Total Revenue

13.1.3 Roche Anti-tumor Drug Introduction

13.1.4 Roche Revenue in Anti-tumor Drug Business (2015-2020))

13.1.5 Roche Recent Development

13.2 Novartis

13.2.1 Novartis Company Details

13.2.2 Novartis Business Overview and Its Total Revenue

13.2.3 Novartis Anti-tumor Drug Introduction

13.2.4 Novartis Revenue in Anti-tumor Drug Business (2015-2020)

13.2.5 Novartis Recent Development

13.3 Celgene

13.3.1 Celgene Company Details

13.3.2 Celgene Business Overview and Its Total Revenue

13.3.3 Celgene Anti-tumor Drug Introduction

13.3.4 Celgene Revenue in Anti-tumor Drug Business (2015-2020)

13.3.5 Celgene Recent Development

13.4 Bristol-Myers Squibb

13.4.1 Bristol-Myers Squibb Company Details

13.4.2 Bristol-Myers Squibb Business Overview and Its Total Revenue

13.4.3 Bristol-Myers Squibb Anti-tumor Drug Introduction

13.4.4 Bristol-Myers Squibb Revenue in Anti-tumor Drug Business (2015-2020)

13.4.5 Bristol-Myers Squibb Recent Development

13.5 Amgen

13.5.1 Amgen Company Details

13.5.2 Amgen Business Overview and Its Total Revenue

13.5.3 Amgen Anti-tumor Drug Introduction

13.5.4 Amgen Revenue in Anti-tumor Drug Business (2015-2020)

13.5.5 Amgen Recent Development

13.6 Johnson & Johnson

13.6.1 Johnson & Johnson Company Details

13.6.2 Johnson & Johnson Business Overview and Its Total Revenue

13.6.3 Johnson & Johnson Anti-tumor Drug Introduction

13.6.4 Johnson & Johnson Revenue in Anti-tumor Drug Business (2015-2020)

13.6.5 Johnson & Johnson Recent Development

13.7 Pfizer

13.7.1 Pfizer Company Details

13.7.2 Pfizer Business Overview and Its Total Revenue

13.7.3 Pfizer Anti-tumor Drug Introduction

13.7.4 Pfizer Revenue in Anti-tumor Drug Business (2015-2020)

13.7.5 Pfizer Recent Development

13.8 Takeda

13.8.1 Takeda Company Details

13.8.2 Takeda Business Overview and Its Total Revenue

13.8.3 Takeda Anti-tumor Drug Introduction

13.8.4 Takeda Revenue in Anti-tumor Drug Business (2015-2020)

13.8.5 Takeda Recent Development

13.9 Eli Lilly

13.9.1 Eli Lilly Company Details

13.9.2 Eli Lilly Business Overview and Its Total Revenue

13.9.3 Eli Lilly Anti-tumor Drug Introduction

13.9.4 Eli Lilly Revenue in Anti-tumor Drug Business (2015-2020)

13.9.5 Eli Lilly Recent Development

13.10 AstraZeneca

13.10.1 AstraZeneca Company Details

13.10.2 AstraZeneca Business Overview and Its Total Revenue

13.10.3 AstraZeneca Anti-tumor Drug Introduction

13.10.4 AstraZeneca Revenue in Anti-tumor Drug Business (2015-2020)

13.10.5 AstraZeneca Recent Development

13.11 Astellas

10.11.1 Astellas Company Details

10.11.2 Astellas Business Overview and Its Total Revenue

10.11.3 Astellas Anti-tumor Drug Introduction

10.11.4 Astellas Revenue in Anti-tumor Drug Business (2015-2020)

10.11.5 Astellas Recent Development

13.12 Merck & Co

10.12.1 Merck & Co Company Details

10.12.2 Merck & Co Business Overview and Its Total Revenue

10.12.3 Merck & Co Anti-tumor Drug Introduction

10.12.4 Merck & Co Revenue in Anti-tumor Drug Business (2015-2020)

10.12.5 Merck & Co Recent Development

13.13 Sanofi

10.13.1 Sanofi Company Details

10.13.2 Sanofi Business Overview and Its Total Revenue

10.13.3 Sanofi Anti-tumor Drug Introduction

10.13.4 Sanofi Revenue in Anti-tumor Drug Business (2015-2020)

10.13.5 Sanofi Recent Development

13.14 Bayer

10.14.1 Bayer Company Details

10.14.2 Bayer Business Overview and Its Total Revenue

10.14.3 Bayer Anti-tumor Drug Introduction

10.14.4 Bayer Revenue in Anti-tumor Drug Business (2015-2020)

10.14.5 Bayer Recent Development

13.15 Biogen Idec

10.15.1 Biogen Idec Company Details

10.15.2 Biogen Idec Business Overview and Its Total Revenue

10.15.3 Biogen Idec Anti-tumor Drug Introduction

10.15.4 Biogen Idec Revenue in Anti-tumor Drug Business (2015-2020)

10.15.5 Biogen Idec Recent Development

13.16 Eisai

10.16.1 Eisai Company Details

10.16.2 Eisai Business Overview and Its Total Revenue

10.16.3 Eisai Anti-tumor Drug Introduction

10.16.4 Eisai Revenue in Anti-tumor Drug Business (2015-2020)

10.16.5 Eisai Recent Development

13.17 Teva

10.17.1 Teva Company Details

10.17.2 Teva Business Overview and Its Total Revenue

10.17.3 Teva Anti-tumor Drug Introduction

10.17.4 Teva Revenue in Anti-tumor Drug Business (2015-2020)

10.17.5 Teva Recent Development

13.18 Otsuka

10.18.1 Otsuka Company Details

10.18.2 Otsuka Business Overview and Its Total Revenue

10.18.3 Otsuka Anti-tumor Drug Introduction

10.18.4 Otsuka Revenue in Anti-tumor Drug Business (2015-2020)

10.18.5 Otsuka Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Disclaimer

15.3 Author Details

If you have any special requirements, please let us know and we will offer you the report as you want.

Fact & Figures

List of Tables

Table 1. Anti-tumor Drug Key Market Segments

Table 2. Key Players Covered: Ranking by Anti-tumor Drug Revenue

Table 3. Ranking of Global Top Anti-tumor Drug Manufacturers by Revenue (US$ Million) in 2019

Table 4. Global Anti-tumor Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026

Table 5. Key Players of Cytotoxic Drugs

Table 6. Key Players of Non-cytotoxic Drugs

Table 7. Global Anti-tumor Drug Market Size Growth by Application (US$ Million): 2020 VS 2026

Table 8. Global Anti-tumor Drug Market Size by Regions (US$ Million): 2020 VS 2026

Table 9. Global Anti-tumor Drug Market Size by Regions (2015-2020) (US$ Million)

Table 10. Global Anti-tumor Drug Market Share by Regions (2015-2020)

Table 11. Global Anti-tumor Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)

Table 12. Global Anti-tumor Drug Market Share by Regions (2021-2026)

Table 13. Market Top Trends

Table 14. Key Drivers: Impact Analysis

Table 15. Key Challenges

Table 16. Anti-tumor Drug Market Growth Strategy

Table 17. Main Points Interviewed from Key Anti-tumor Drug Players

Table 18. Global Anti-tumor Drug Revenue by Players (2015-2020) (Million US$)

Table 19. Global Anti-tumor Drug Market Share by Players (2015-2020)

Table 20. Global Top Anti-tumor Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-tumor Drug as of 2019)

Table 21. Global Anti-tumor Drug by Players Market Concentration Ratio (CR5 and HHI)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Anti-tumor Drug Product Solution and Service

Table 24. Date of Enter into Anti-tumor Drug Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Anti-tumor Drug Market Size by Type (2015-2020) (Million US$)

Table 27. Global Anti-tumor Drug Market Size Share by Type (2015-2020)

Table 28. Global Anti-tumor Drug Revenue Market Share by Type (2021-2026)

Table 29. Global Anti-tumor Drug Market Size Share by Application (2015-2020)

Table 30. Global Anti-tumor Drug Market Size by Application (2015-2020) (Million US$)

Table 31. Global Anti-tumor Drug Market Size Share by Application (2021-2026)

Table 32. North America Key Players Anti-tumor Drug Revenue (2019-2020) (Million US$)

Table 33. North America Key Players Anti-tumor Drug Market Share (2019-2020)

Table 34. North America Anti-tumor Drug Market Size by Type (2015-2020) (Million US$)

Table 35. North America Anti-tumor Drug Market Share by Type (2015-2020)

Table 36. North America Anti-tumor Drug Market Size by Application (2015-2020) (Million US$)

Table 37. North America Anti-tumor Drug Market Share by Application (2015-2020)

Table 38. Europe Key Players Anti-tumor Drug Revenue (2019-2020) (Million US$)

Table 39. Europe Key Players Anti-tumor Drug Market Share (2019-2020)

Table 40. Europe Anti-tumor Drug Market Size by Type (2015-2020) (Million US$)

Table 41. Europe Anti-tumor Drug Market Share by Type (2015-2020)

Table 42. Europe Anti-tumor Drug Market Size by Application (2015-2020) (Million US$)

Table 43. Europe Anti-tumor Drug Market Share by Application (2015-2020)

Table 44. China Key Players Anti-tumor Drug Revenue (2019-2020) (Million US$)

Table 45. China Key Players Anti-tumor Drug Market Share (2019-2020)

Table 46. China Anti-tumor Drug Market Size by Type (2015-2020) (Million US$)

Table 47. China Anti-tumor Drug Market Share by Type (2015-2020)

Table 48. China Anti-tumor Drug Market Size by Application (2015-2020) (Million US$)

Table 49. China Anti-tumor Drug Market Share by Application (2015-2020)

Table 50. Japan Key Players Anti-tumor Drug Revenue (2019-2020) (Million US$)

Table 51. Japan Key Players Anti-tumor Drug Market Share (2019-2020)

Table 52. Japan Anti-tumor Drug Market Size by Type (2015-2020) (Million US$)

Table 53. Japan Anti-tumor Drug Market Share by Type (2015-2020)

Table 54. Japan Anti-tumor Drug Market Size by Application (2015-2020) (Million US$)

Table 55. Japan Anti-tumor Drug Market Share by Application (2015-2020)

Table 56. Southeast Asia Key Players Anti-tumor Drug Revenue (2019-2020) (Million US$)

Table 57. Southeast Asia Key Players Anti-tumor Drug Market Share (2019-2020)

Table 58. Southeast Asia Anti-tumor Drug Market Size by Type (2015-2020) (Million US$)

Table 59. Southeast Asia Anti-tumor Drug Market Share by Type (2015-2020)

Table 60. Southeast Asia Anti-tumor Drug Market Size by Application (2015-2020) (Million US$)

Table 61. Southeast Asia Anti-tumor Drug Market Share by Application (2015-2020)

Table 62. India Key Players Anti-tumor Drug Revenue (2019-2020) (Million US$)

Table 63. India Key Players Anti-tumor Drug Market Share (2019-2020)

Table 64. India Anti-tumor Drug Market Size by Type (2015-2020) (Million US$)

Table 65. India Anti-tumor Drug Market Share by Type (2015-2020)

Table 66. India Anti-tumor Drug Market Size by Application (2015-2020) (Million US$)

Table 67. India Anti-tumor Drug Market Share by Application (2015-2020)

Table 68. Central & South America Key Players Anti-tumor Drug Revenue (2019-2020) (Million US$)

Table 69. Central & South America Key Players Anti-tumor Drug Market Share (2019-2020)

Table 70. Central & South America Anti-tumor Drug Market Size by Type (2015-2020) (Million US$)

Table 71. Central & South America Anti-tumor Drug Market Share by Type (2015-2020)

Table 72. Central & South America Anti-tumor Drug Market Size by Application (2015-2020) (Million US$)

Table 73. Central & South America Anti-tumor Drug Market Share by Application (2015-2020)

Table 74. Roche Company Details

Table 75. Roche Business Overview

Table 76. Roche Product

Table 77. Roche Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 78. Roche Recent Development

Table 79. Novartis Company Details

Table 80. Novartis Business Overview

Table 81. Novartis Product

Table 82. Novartis Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 83. Novartis Recent Development

Table 84. Celgene Company Details

Table 85. Celgene Business Overview

Table 86. Celgene Product

Table 87. Celgene Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 88. Celgene Recent Development

Table 89. Bristol-Myers Squibb Company Details

Table 90. Bristol-Myers Squibb Business Overview

Table 91. Bristol-Myers Squibb Product

Table 92. Bristol-Myers Squibb Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 93. Bristol-Myers Squibb Recent Development

Table 94. Amgen Company Details

Table 95. Amgen Business Overview

Table 96. Amgen Product

Table 97. Amgen Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 98. Amgen Recent Development

Table 99. Johnson & Johnson Company Details

Table 100. Johnson & Johnson Business Overview

Table 101. Johnson & Johnson Product

Table 102. Johnson & Johnson Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 103. Johnson & Johnson Recent Development

Table 104. Pfizer Company Details

Table 105. Pfizer Business Overview

Table 106. Pfizer Product

Table 107. Pfizer Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 108. Pfizer Recent Development

Table 109. Takeda Business Overview

Table 110. Takeda Product

Table 111. Takeda Company Details

Table 112. Takeda Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 113. Takeda Recent Development

Table 114. Eli Lilly Company Details

Table 115. Eli Lilly Business Overview

Table 116. Eli Lilly Product

Table 117. Eli Lilly Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 118. Eli Lilly Recent Development

Table 119. AstraZeneca Company Details

Table 120. AstraZeneca Business Overview

Table 121. AstraZeneca Product

Table 122. AstraZeneca Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 123. AstraZeneca Recent Development

Table 124. Astellas Company Details

Table 125. Astellas Business Overview

Table 126. Astellas Product

Table 127. Astellas Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 128. Astellas Recent Development

Table 129. Merck & Co Company Details

Table 130. Merck & Co Business Overview

Table 131. Merck & Co Product

Table 132. Merck & Co Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 133. Merck & Co Recent Development

Table 134. Sanofi Company Details

Table 135. Sanofi Business Overview

Table 136. Sanofi Product

Table 137. Sanofi Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 138. Sanofi Recent Development

Table 139. Bayer Company Details

Table 140. Bayer Business Overview

Table 141. Bayer Product

Table 142. Bayer Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 143. Bayer Recent Development

Table 144. Biogen Idec Company Details

Table 145. Biogen Idec Business Overview

Table 146. Biogen Idec Product

Table 147. Biogen Idec Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 148. Biogen Idec Recent Development

Table 149. Eisai Company Details

Table 150. Eisai Business Overview

Table 151. Eisai Product

Table 152. Eisai Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 153. Eisai Recent Development

Table 154. Teva Company Details

Table 155. Teva Business Overview

Table 156. Teva Product

Table 157. Teva Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 158. Teva Recent Development

Table 159. Otsuka Company Details

Table 160. Otsuka Business Overview

Table 161. Otsuka Product

Table 162. Otsuka Revenue in Anti-tumor Drug Business (2015-2020) (Million US$)

Table 163. Otsuka Recent Development

Table 164. Research Programs/Design for This Report

Table 165. Key Data Information from Secondary Sources

Table 166. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Anti-tumor Drug Market Share by Type: 2020 VS 2026

Figure 2. Cytotoxic Drugs Features

Figure 3. Non-cytotoxic Drugs Features

Figure 4. Global Anti-tumor Drug Market Share by Application: 2020 VS 2026

Figure 5. Alkylating Agents Case Studies

Figure 6. Anti-metabolism Drugs Case Studies

Figure 7. Platinum Antineoplastic Agents Case Studies

Figure 8. Anthracycline antitumor drugs Case Studies

Figure 9. Microtubule Stabilizer Case Studies

Figure 10. Endocrine Therapy Drugs Case Studies

Figure 11. Immunotherapy Drugs Case Studies

Figure 12. Gene Therapy Drugs Case Studies

Figure 13. Targeted Antineoplastic Drugs Case Studies

Figure 14. Anti-tumor Drug Report Years Considered

Figure 15. Global Anti-tumor Drug Market Size YoY Growth 2015-2026 (US$ Million)

Figure 16. Global Anti-tumor Drug Market Share by Regions: 2020 VS 2026

Figure 17. Global Anti-tumor Drug Market Share by Regions (2021-2026)

Figure 18. Porter's Five Forces Analysis

Figure 19. Global Anti-tumor Drug Market Share by Players in 2019

Figure 20. Global Top Anti-tumor Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-tumor Drug as of 2019

Figure 21. The Top 10 and 5 Players Market Share by Anti-tumor Drug Revenue in 2019

Figure 22. North America Anti-tumor Drug Market Size YoY Growth (2015-2020) (Million US$)

Figure 23. Europe Anti-tumor Drug Market Size YoY Growth (2015-2020) (Million US$)

Figure 24. China Anti-tumor Drug Market Size YoY Growth (2015-2020) (Million US$)

Figure 25. Japan Anti-tumor Drug Market Size YoY Growth (2015-2020) (Million US$)

Figure 26. Southeast Asia Anti-tumor Drug Market Size YoY Growth (2015-2020) (Million US$)

Figure 27. India Anti-tumor Drug Market Size YoY Growth (2015-2020) (Million US$)

Figure 28. Central & South America Anti-tumor Drug Market Size YoY Growth (2015-2020) (Million US$)

Figure 29. Roche Total Revenue (US$ Million): 2019 Compared with 2018

Figure 30. Roche Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 31. Novartis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 32. Novartis Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 33. Celgene Total Revenue (US$ Million): 2019 Compared with 2018

Figure 34. Celgene Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 35. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018

Figure 36. Bristol-Myers Squibb Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 37. Amgen Total Revenue (US$ Million): 2019 Compared with 2018

Figure 38. Amgen Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 39. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018

Figure 40. Johnson & Johnson Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 41. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 42. Pfizer Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 43. Takeda Total Revenue (US$ Million): 2019 Compared with 2018

Figure 44. Takeda Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 45. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018

Figure 46. Eli Lilly Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 47. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018

Figure 48. AstraZeneca Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 49. Astellas Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. Astellas Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 51. Merck & Co Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Merck & Co Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 53. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. Sanofi Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 55. Bayer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 56. Bayer Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 57. Biogen Idec Total Revenue (US$ Million): 2019 Compared with 2018

Figure 58. Biogen Idec Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 59. Eisai Total Revenue (US$ Million): 2019 Compared with 2018

Figure 60. Eisai Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 61. Teva Total Revenue (US$ Million): 2019 Compared with 2018

Figure 62. Teva Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 63. Otsuka Total Revenue (US$ Million): 2019 Compared with 2018

Figure 64. Otsuka Revenue Growth Rate in Anti-tumor Drug Business (2015-2020)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

If you have any special requirements, please let us know and we will offer you the report as you want.

Please share youre basic details, to recieve the report sample

If you have any special requirements, please let us know and we will offer you the report as you want.

Our Clients

dropbox
kodak
honeywell
philips
nestle
Hanwha
Compass-Minerals
Elanco
Honda-Europe
Courant.Biz | Powered By SAIME DIGITAL TECHNOLOGIES PVT. LTD. | © 2020